z-logo
open-access-imgOpen Access
Risperidone as an effective choice for obsessive–compulsive symptoms and tardive dyskinesia in an Indian quadragenarian with schizo-obsessive disorder
Author(s) -
Ameeya Kumar Nayak,
Heena Merchant,
Hrishikesh B Nachane,
Aditya R Anvekar
Publication year - 2019
Publication title -
indian journal of psychiatry/indian journal of psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.485
H-Index - 34
eISSN - 1998-3794
pISSN - 0019-5545
DOI - 10.4103/psychiatry.indianjpsychiatry_414_18
Subject(s) - tardive dyskinesia , risperidone , obsessive compulsive , psychiatry , psychology , medicine , psychotherapist , schizophrenia (object oriented programming)
Tardive dyskinesia (TD) is a chronic, stigmatizing side effect of typical and atypical antipsychotics that is often debilitating for the patient and resistant to treatment. Obsessive-compulsive symptoms (OCS) may arise at any stage of schizophrenia ranging from prodrome to posttreatment and carry a poor prognosis. Management of both the conditions is a challenging and often fatiguing task for the treating physician. We report a case of schizo-obsessive disorder in an Indian quadragenarian who had developed TD with olanzapine and had failed to show improvement with clozapine and quetiapine. The patient improved dramatically with risperidone. Our findings corroborate with previous literature which has shown risperidone to be effective in treatment of TD and obsessive symptoms, possibly due to its action on the serotonergic system. The authors conclude that risperidone is an effective choice to treat TD and comorbid OCS in patients with schizophrenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here